SS Innovations applies for FDA approval for its Mantra robotic surgical system

Neutral 0.0
SS Innovations, a developer of innovative surgical robotic technologies, has submitted a 510(k) premarket notification to the US Food and Drug Administration for the SSI Mantra surgical robotic system for multiple specialty procedure types, including: general, urological, colorectal, gynecological, and cardiac surgery.  Dr Sudhir Srivastava, chairman CEO of SS Innovations, says: “Our submission of a […]
Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.